Adapter protein and gene encoding it
CA 2429856 A1 · Owner: Mcglade, Jane C. · Inventors: Loreto, Michael P.; Mcglade, Jane C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the identification and cloning of a novel gene, MARS (Modulator of Antigen Receptor Signaling) which is a putative , tumor suppressor gene. The present invention also relates to the relation of the MARS gene to human cancers and its use in the diagnosis and prognosis of human cancer. The invention also relates to the therapy of human cancers which have a mutation in the MARS gene, or lack the MARS gene including gene , therapy, protein replacement therapy and protein mimetics. Finally the , invention relates to the screening of drugs for cancer therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.